65 results found.
      
BARE BONES® - February 25, 2014
Integra LifeSciences reported 4Q13 orthopaedic revenue of US $82.7MM, +5% from 4Q12, and 2013 orthopaedic revenue of $314.6MM, +0.4% from 2012. (2013 by segment: U.S. Extremities $134.6MM, +10%
4Q13/2013 Revenue: Integra LifeSciences
4Q13 orthopaedic revenue: $82.7MM, +5% Extremities +13% (U.S. +16%) Orthopaedics +7% U.S. Spine & Other -3%   Extremities led by hardware growth +20% (citing controlled market release of Titan sh...
BARE BONES® - October 28, 2013
Integra LifeSciences reported 3Q13 orthopaedic revenue of ~US $80.4MM, -2% from 3Q12. (U.S. Extremities $33.5MM, +2%, U.S. Spine & Other $46.9MM, -5%) (
3Q13 Revenue: Integra LifeSciences
$80.4MM, -2% U.S. Extremities $33.5MM, +2% (Hardware +10%) U.S. Spine & Other $46.9MM, -5% Extremities includes products serving the skin and wound repair markets ~60% soft tissue/40% metal)   Increasing orth...
BARE BONES® - August 1, 2013
Integra LifeSciences reported 2Q13 orthopaedic revenue of US $76.5MM, -5% from 2Q12. (U.S. Extremities $33.5MM, +5%, U.S. Spine & Other $42.9MM, -12%) (
2Q13 Revenue: Integra LifeSciences
Orthopaedic sales $76.5MM, -5% U.S. Extremities $33.5MM, +5% U.S. Spine & Other $42.9MM, -12%   Orthobiologics flat due to backorders in collagen and ceramic bone void fillers; supply should return to normal by end ...
BARE BONES® - May 2, 2013
Integra LifeSciences reported 1Q13 orthopaedic revenue of US $74.9MM, +5% from 1Q12. (U.S. Extremities $31.3MM, +18%, U.S. Spine & Other $43.5MM, -2.8%) (
1Q13 Revenue: Integra LifeSciences
$74.9MM, +5% U.S. Extremities $31.3MM, +18% U.S. Spine & Other $43.5MM, -3%   Private label ortho products down in low-single-digits Extremities driven by regenerative medicine, foot/ankle; all franchises...
BARE BONES® - February 21, 2013
Integra LifeSciences reported 4Q12 orthopaedic revenue of US $93.2MM, +4% from 4Q11, and 2012 revenue of $369.3MM, +12% from 2011. (2012 U.S. $312.8MM, +15%; ex-U.S. $56.4MM, -1%) (Growth refl...
BARE BONES® - October 24, 2012
Integra Orthopedics posted 3Q12 revenue of US $94.1MM, +9.9% from 3Q11. (U.S. $82.0MM, +12.5%; ex-U.S. $12.1MM, -4.9%; U.S. Extremities $32.9MM, +32.8%; U.S. Spine & Other $49.1MM, +1....
Final 2Q12 Results
ORTHOWORLD’s estimates place 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted.  Exhibit 1 Ort...
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - July 26, 2012
Integra LifeSciences reported 2Q12 orthopaedic revenue of US $95.6MM, +17% from 2Q11. (U.S. $80.7MM, +22%, ex-U.S. $14.9MM, -2%) (
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
BARE BONES® - April 25, 2012
Integra LifeSciences reported 1Q12 orthopaedic revenue of US $86.1MM, +19% from 1Q11. (U.S. $71.2MM, +22%; ex-U.S. $14.9MM, +9%; U.S. Extremities $26.5MM, +25%, U.S. Spine & Other $44....
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group